Thomas Van Dyke

Adjunct Professor of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine

Thomas Van Dyke

Thomas Van Dyke

Adjunct Professor of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine

Biography

Mr. Thomas E. Van Dyke is Co-Founder at Resolvyx Pharmaceuticals, Inc.

Overview
Career Highlights

Resolvyx Pharmaceuticals, Inc.

RelSci Relationships

974

Number of Boards

1

Relationships
RelSci Relationships are individuals Thomas Van Dyke likely has professional access to. A relationship does not necessarily indicate a personal connection.

Interim Chief Executive Officer & Executive Publisher, Science Family of Journals at American Association for the Advancement of Science

Relationship likelihood: Strong

President-Elect & Director at American Association for the Advancement of Science

Relationship likelihood: Strong

Senior Project Director, Science & Technology Policy Fellowships at American Association for the Advancement of Science

Relationship likelihood: Strong

Program Director, STEM Education Research at American Association for the Advancement of Science

Relationship likelihood: Strong

Director, Scientific Responsibility, Human Rights & Law Program at American Association for the Advancement of Science

Relationship likelihood: Strong

Director, Federal Relations at American Association for the Advancement of Science

Relationship likelihood: Strong

Project Director, Science & Technology Policy Fellowships at American Association for the Advancement of Science

Relationship likelihood: Strong

Administrative Coordinator, Eurekalert at American Association for the Advancement of Science

Relationship likelihood: Strong

Chief Executive Officer at American Association for the Advancement of Science

Relationship likelihood: Strong

Chief Financial Officer & Chief Legal Officer at American Association for the Advancement of Science

Relationship likelihood: Strong

Paths to Thomas Van Dyke
Potential Connections via
Relationship Science
You
Thomas Van Dyke
Adjunct Professor of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine
Career History
Co-Founder
2001 - Prior

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA.

Adjunct Professor of Molecular & Cell Biology
Current
Boards & Committees
Member, Dentistry & Oral Health Sciences Section Steering Group
Current

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

Investments
Details Hidden

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thomas Van Dyke. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thomas Van Dyke's profile does not indicate a business or promotional relationship of any kind between RelSci and Thomas Van Dyke.